Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
414.65
Change Change %
-8.25 -1.95%

Updated:18 Feb, 2019, 15:59 PM IST

BSE
415.10
Change Change %
-8.20 -1.94%

Updated:18 Feb, 2019, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Bank of America Merrill Lynch
N/A
16-08-2016 Hold 801.80 N/A
N/A
Closed Long (1Y)
16-08-2017

Bank of America Merrill Lynch downgrades Sun Pharma

Bank of America Merrill Lynch has downgraded Sun Pharma to neutral from buy for target price of Rs 855/share. It says Taro is facing increasing competition and US growth is likely to moderate from here on. BofAML adds that it prefer Lupin over Sun Pharma.

Top